Business Growth Fund

Not financial or fundraising advice. See full disclaimer.

Tickets

£2M - £10M

Rounds

Series A
Later Rounds

Sectors

Climate / Green
Deep Tech
Life Sciences

Target Geography

United Kingdom
Europe

Last Edited:

October 2, 2025

To suggest a correction to the database, or request to be added or removed from it, contact us at info@adeline.co.uk.

Amid the noisy rush of venture capital, the Business Growth Fund (BGF) stands out with a distinctly different style. Founded in 2011 after the financial crisis, BGF emerged as an unconventional investor, set up by major UK banks to tackle a persistent funding gap for SMEs. Unlike many institutional funds chasing rapid returns, BGF offers something appealingly counterintuitive: patient capital, a steady hand, and no fixed timeline to cash out.

Operating nationwide from Aberdeen to Bristol and Belfast to Cambridge, BGF has invested over £4 billion into more than 600 companies, making it one of the UK’s most prolific investors. The fund's nationwide network and commitment to regional engagement distinguish it from more London-centric investors. It refuses to chase majority stakes, instead investing in minority equity positions—typically between £3 million and £30 million initially—to allow entrepreneurs room to lead. Andy Gregory, who took over as CEO in late 2022, stresses the firm’s role as a supportive partner rather than a controller. It’s a crucial distinction for founders wary of surrendering strategic direction.

BGF's expansive portfolio underscores its sector-agnostic nature. Notable investments include Gousto, the meal-kit unicorn, Gymbox, a popular London fitness chain, and clean-energy innovator Bramble Energy. While it typically invests in established ventures ready to scale, BGF also maintains a targeted early-stage focus in IP-rich sectors like deep tech, life sciences, and climate tech, providing seed or Series A funding as high as £10 million.

Founders approaching BGF should anticipate a thorough due diligence process and be prepared to demonstrate clear growth plans, commercial traction, or robust intellectual property, depending on their sector. Importantly, BGF isn't suited to founders seeking small initial rounds or those still refining their product-market fit. However, once a startup hits its stride, the fund’s ability to provide follow-on financing can support businesses through multiple stages of growth.

Entrepreneurs who've partnered with BGF often emphasize its balanced, relationship-driven approach. Royston Bayfield, founder of Bayfields Opticians, praised the fund as "hands-off, but a bit like family—always there if you need them," capturing the essence of BGF’s supportive-but-not-intrusive ethos. Similarly, Vikki Jackson-Smith of J&B Recycling highlighted how BGF delivered not only capital but critical insight, describing their involvement as the "perfect combination."

For entrepreneurs planning their funding journey, BGF offers a potential bridge from early traction to meaningful scale—a growth partner who invests for the long haul without rushing for the exit.

Pitch Adeline Arts & Science

Adeline is a London-based family office investing in pre-seed, seed and series A startups.

£2M - £10M
Series A
Later Rounds
Climate / Green
Deep Tech
Life Sciences
United Kingdom
Europe

The AI operating system for private capital: why we invested in Capsa AI

Adeline Arts & Science has backed Capsa AI, joining their $18 million Series A co-led by TX Ventures and Pivot Investment Partners. Capsa turns a private capital firm's accumulated deal history and institutional knowledge into a live intelligence layer, surfacing insights and automating the critical workflows that matter most for investment teams.

Read More
Arrow pointing right

Preventing Hospital Outbreaks with Predictive AI: Why Adeline is backing NEX Health Intelligence

Adeline Arts and Science has backed NEX Health Intelligence, joining their €1 million pre-seed round alongside lead investor Brighteye Ventures and a syndicate of early backers. NEX is building the Infection Intelligence Platform for modern hospitals — a system that moves infection prevention from reactive surveillance to predictive action.

Read More
Arrow pointing right